anti-idiotype_2022
Idiotypes are antigenic determinants located in the variable region of antibodies. An anti-idiotype antibody can specifically bind to an idiotype of another antibody, usually an antibody drug. Hence, anti-idiotype antibodies can be used in preclinical practices for pharmacokinetic (PK) analysis to measure antibody drug levels. Since an anti-idotype antibody is very similar to an anti-drug antibody (ADA), anti-idiotype antibodies can also be used as positive controls for immunogenicity assays.
GenScript has developed a broad range of off-the-shelf anti-idiotype antibodies against blockbuster drugs to help accelerate your research of biosimilars.
Benefits
-
100+ Products
Against 28 monoclonal
antibody drugs -
Ready-to-use Anti-ID Pairs
Various pre-validated anti-ID
pairs for PK study -
High Sensitivity MonoRab™ mAb
Perfect for picomolar-level
immunoassay
Pharmacokinetic (PK)
studies: Used to measure the drug level in patient samples
Immunogenicity (anti-drug
antibody, ADA) assays: Used as a positive control or reference
standards
- Isotype Control Antibodies
- THE PEG Antibody
| Cat. No. | Product Name | Quantity | Price |
|---|---|---|---|
A01795-500 |
THE™ PEG Antibody, mAb, Mouse - 500 μg | - | |
A01795-100 |
THE™ PEG Antibody, mAb, Mouse - 100 μg | - | |
A01796-100 |
THE™ PEG Antibody [Biotin], mAb, Mouse - 100 μg | - |
- Anti-Adalimumab/Humira (Target: TNF alpha)
- Anti-Atezolizumab/Tecentriq (Target: PD-L1)
- Anti-Avelumab/Bavencio (Target: PD-L1)
- Anti-Bevacizumab/Avastin (Target: VEGF-A)
- Anti-Cetuximab/Erbitux (Target: EGF Receptor)
- Anti-Daratumumab/Darzalex (Target: CD38)
- Anti-Denosumab/Prolia (Target: RANK Ligand)
- Anti-Dupilumab/Dupixent (Target: IL-4Rα)
- Anti-Durvalumab/Imfinzi (Target: CD274)
- Anti-Eculizumab/Soliris (Target: Complement protein C5)
- Anti-Etanercept/Enbrel (Target: TNF alpha)
- Anti-Golimumab/Simponi (Target: TNF alpha)
- Anti-Infliximab/Remicade (Target: TNF alpha)
- Anti-Ipilimumab/Yervoy (Target: CTLA-4)
- Anti-Nivolumab/Opdivo (Target: PD-1)
- Anti-Obinutuzumab/Gazyva (Target: CD20)
- Anti-Omalizumab/Xolair (Target: Human IgE)
- Anti-Palivizumab/Synagis (Target: RSV F)
- Anti-Panitumumab/Vectibix (Target: EGF Receptor)
- Anti-Pembrolizumab/Keytruda (Target: PD-1)
- Anti-Pertuzumab/Perjeta (Target: HER2)
- Anti-Ranibizumab/Lucentis (Target: VEGF-A)
- Anti-Rituximab/Rituxan (Target: CD20)
- Anti-Sarilumab/Kevzara (Target: IL-6 Receptor)
- Anti-Secukinumab/Cosentyx (Target: IL-17A)
- Anti-Tocilizumab/Actemra (Target: IL-6 Receptor)
- Anti-Trastuzumab/Herceptin (Target: HER2)
- Anti-Ustekinumab/Stelara (Target: IL-12 & IL-23)
Anti-Adalimumab/Humira (Target: TNF alpha)
| Cat. No. | Product Name | Inhibitory IC50 (μg/ml) | Recommend Applications | Recommended Pairs (Capture-Detection) |
|---|---|---|---|---|
| A01954-40 | Anti-Adalimumab Antibody (15C7), mAb, Mouse | 0.258 | ELISA, PK study | A01954-40 (C) - A01955-40 (D) A01954-40 (C) - A01956-40 (D) |
| A01955-40 | Anti-Adalimumab Antibody (3C2), mAb, Mouse | Non-inhibitory | ELISA, PK study | |
| A01956-40 | Anti-Adalimumab Antibody (3C2) [Biotin], mAb, Mouse | - | ELISA, PK study | |
| A01921-40 | MonoRab™ Anti-Adalimumab Antibody (4E12), mAb, Rabbit | 0.175 | ELISA, PK study | A01921-40 (C) - A01922-40 (D) |
| A01922-40 | MonoRab™ Anti-Adalimumab Antibody (134D5), mAb, Rabbit | 0.353 | ELISA, PK study | |
| A01923-40 | MonoRab™ Anti-Adalimumab Antibody (196F3), mAb, Rabbit | Non-inhibitory | ELISA, PK study | - |
| A01886-40 | Anti-Adalimumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
Anti-Atezolizumab/Tecentriq (Target: PD-L1)
| Cat. No. | Product Name | Inhibitory IC50 (μg/ml) | Recommend Applications | Recommended Pairs (Capture-Detection) |
|---|---|---|---|---|
| A01948-40 | Anti-Atezolizumab Antibody (10G9), mAb, Mouse | 0.118 | ELISA, PK study |
A01948-40 (C) - A01949-40 (D) A01948-40 (C) - A01950-40 (D) |
| A01949-40 | Anti-Atezolizumab Antibody (6B12), mAb, Mouse | Non-inhibitory | ELISA, PK study | |
| A01950-40 | Anti-Atezolizumab Antibody (6B12) [Biotin], mAb, Mouse | - | ELISA, PK study | |
| A01984-40 | MonoRab™ Anti-Atezolizumab Antibody (55D8) mAb, Rabbit | 0.391 | ELISA, PK study |
A01984-40 (C) - A01985-40 (D) A01984-40 (C) - A01986-40 (D) |
| A01985-40 | MonoRab™ Anti-Atezolizumab Antibody (43H11), mAb, Rabbit | 0.847 | ELISA, PK study | |
| A01986-40 | MonoRab™ Anti-Atezolizumab Antibody (43H11)[Biotin], mAb, Rabbit | - | ELISA, PK study |
Anti-Avelumab/Bavencio (Target: PD-L1)
| Cat. No. | Product Name | Inhibitory IC50 (μg/ml) | Recommend Applications | Recommended Pairs (Capture-Detection) |
|---|---|---|---|---|
| A02121-40 | Anti-Avelumab Antibody (12H7), mAb, Mouse | 0.748 | ELISA, PK study | A02121-40 (C) - A02120-40 (D) |
| A02120-40 | Anti-Avelumab Antibody (12G9), mAb, Mouse | 0.741 | ELISA, PK study |
Anti-Bevacizumab/Avastin (Target: VEGF-A)
| Cat. No. | Product Name | Inhibitory IC50 (μg/ml) | Recommend Applications | Recommended Pairs (Capture-Detection) |
|---|---|---|---|---|
| A01975-40 | Anti-Bevacizumab Antibody (4H1), mAb, Mouse | Non-inhibitory | ELISA, PK study |
A01975-40 (C) - A01976-40 (D) A01975-40 (C) - A01977-40 (D) |
| A01976-40 | Anti-Bevacizumab Antibody (6C3), mAb, Mouse | 0.157 | ELISA, PK study | |
| A01977-40 | Anti-Bevacizumab Antibody (6C3)[Biotin], mAb, Mouse | - | ELISA, PK study | |
| A01895-40 | MonoRab™ Anti-Bevacizumab Antibody (30E1), mAb, Rabbit | Non-inhibitory | ELISA, PK study | A01895-40 (C) - A01962-40 (D) A01895-40 (C) - A01896-40 (D) |
| A01962-40 | MonoRab™ Anti-Bevacizumab Antibody (46E3), mAb, Rabbit | 0.046 | ELISA, PK study | |
| A01896-40 | MonoRab™ Anti-Bevacizumab Antibody (46E3)[Biotin], mAb, Rabbit | - | ELISA, PK study | |
| A01887-40 | Anti-Bevacizumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
Anti-Cetuximab/Erbitux (Target: EGF Receptor)
| Cat. No. | Product Name | Inhibitory IC50 (μg/ml) | Recommend Applications | Recommended Pairs (Capture-Detection) |
|---|---|---|---|---|
| A01939-40 | Anti-Cetuximab Antibody (20H1), mAb, Mouse | Non-inhibitory | ELISA, PK study | A01939-40 (C) - A01938-40 (D) |
| A01938-40 | Anti-Cetuximab Antibody (18D5), mAb, Mouse | 0.2073 | ELISA, PK study | |
| A01991-40 | MonoRab™ Anti-Cetuximab Antibody (69H10), mAb, Rabbit | 0.039 | ELISA, PK study | A01991-40 (C) - A01992-40 (D) |
| A01992-40 | MonoRab™ Anti-Cetuximab Antibody (90G3), mAb, Rabbit | 0.015 | ELISA, PK study | |
| A01993-40 | Anti-Cetuximab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
Anti-Daratumumab/Darzalex (Target: CD38)
| Cat. No. | Product Name | Inhibitory IC50 (μg/ml) | Recommend Applications | Recommended Pairs (Capture-Detection) |
|---|---|---|---|---|
| A01996-40 | Anti-Daratumumab Antibody (11F2), mAb, Mouse | Non-inhibitory | ELISA, PK study | A01996-40 (C) - A01997-40 (D) |
| A01997-40 | Anti-Daratumumab Antibody (6A3), mAb, Mouse | 0.582 | ELISA, PK study | |
| A01998-40 | Anti-Daratumumab Antibody (9A6), mAb, Mouse | 0.118 | ELISA, PK study | - |
| A02009-40 | MonoRab™ Anti-Daratumumab(139B10), mAb, Rabbit | 0.017 | ELISA, PK study | - |
Anti-Denosumab/Prolia (Target: RANK Ligand)
| Cat. No. | Product Name | Inhibitory IC50 (μg/ml) | Recommend Applications | Recommended Pairs (Capture-Detection) |
|---|---|---|---|---|
| A02101-40 | Anti-Denosumab Antibody (2H7), mAb, Mouse | Non-inhibitory | ELISA, PK study | A02101-40 (C) - A02102-40 (D) |
| A02102-40 | Anti-Denosumab Antibody (9A10), mAb, Mouse | 0.893 | ELISA, PK study |
Anti-Dupilumab/Dupixent (Target: IL-4Rα)
| Cat. No. | Product Name | Inhibitory IC50 (μg/ml) | Recommend Applications | Recommended Pairs (Capture-Detection) |
|---|---|---|---|---|
| A02098-40 | Anti-Dupilumab Antibody (6C9), mAb, Mouse | 0.185 | ELISA, PK study | A02098-40 (C) - A02097-40 (D) |
| A02097-40 | Anti-Dupilumab Antibody (2D5), mAb, Mouse | 0.174 | ELISA, PK study | |
| A02062-40 | Anti-Dupilumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
Anti-Durvalumab/Imfinzi (Target: CD274)
| Cat. No. | Product Name | Inhibitory IC50 (μg/ml) | Recommend Applications | Recommended Pairs (Capture-Detection) |
|---|---|---|---|---|
| A02029-40 | Anti-Durvalumab Antibody (7B6), mAb, Mouse | Non-inhibitory | ELISA, PK study | A02029-40 (C) - A02030-40 (D) |
| A02030-40 | Anti-Durvalumab Antibody (4B5), mAb, Mouse | Non-inhibitory | ELISA, PK study | |
| A02031-40 | Anti-Durvalumab Antibody (15D6), mAb, Mouse | 1.37 | ELISA, PK study | - |
| A02010-40 | Anti-Durvalumab Antibody, pAb, Rabbit | - | ELISA,Immunogenicity assay | - |
Anti-Eculizumab/Soliris (Target: Complement protein C5)
| Cat. No. | Product Name | Inhibitory IC50 (μg/ml) | Recommend Applications | Recommended Pairs (Capture-Detection) |
|---|---|---|---|---|
| A02115-40 | Anti-Eculizumab Antibody (4F6), mAb, Mouse | Non-inhibitory | ELISA, PK study | A02115-40 (C) - A02116-40 (D) |
| A02116-40 | Anti-Eculizumab Antibody(13F5), mAb, Mouse | 1.053 | ELISA, PK study |
Anti-Etanercept/Enbrel (Target: TNF alpha)
| Cat. No. | Product Name | Inhibitory IC50 (μg/ml) | Recommend Applications | Recommended Pairs (Capture-Detection) |
|---|---|---|---|---|
| A02114-40 | Anti-Etanercept Antibody (4H5), mAb, Mouse | 0.467 | ELISA, PK study | A02114-40 (C) - A02113-40 (D) |
| A02113-40 | Anti-Etanercept Antibody (4H1), mAb, Mouse | Non-inhibitory | ELISA, PK study |
Anti-Golimumab/Simponi (Target: TNF alpha)
| Cat. No. | Product Name | Inhibitory IC50 (μg/ml) | Recommend Applications | Recommended Pairs (Capture-Detection) |
|---|---|---|---|---|
| A02093-40 | Anti-Golimumab Antibody, pAb, Rabbit | - | Direct ELISA, Immunogenicity assay | - |
Anti-Infliximab/Remicade (Target: TNF alpha)
| Cat. No. | Product Name | Inhibitory IC50 (μg/ml) | Recommend Applications | Recommended Pairs (Capture-Detection) |
|---|---|---|---|---|
| A02040-40 | Anti-Infliximab Antibody (27A4) , mAb, Mouse | Non-inhibitory | ELISA, PK study | A02040-40 (C) - A02041-40 (D) |
| A02041-40 | Anti-Infliximab Antibody (23H5) , mAb, Mouse | Non-inhibitory | ELISA, PK study | |
| A02061-40 | Anti-Infliximab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
Anti-Ipilimumab/Yervoy (Target: CTLA-4)
| Cat. No. | Product Name | Inhibitory IC50 (μg/ml) | Recommend Applications | Recommended Pairs (Capture-Detection) |
|---|---|---|---|---|
| A01859-40 | Anti-Ipilimumab Antibody(26B6H7D9), mAb, Mouse | Non-inhibitory | ELISA, PK study |
A01859-40 (C) - A01961-40 (D) A01859-40 (C) - A01858-40 (D) |
| A01961-40 | Anti-Ipilimumab Antibody (4H6), mAb, Mouse | Non-inhibitory | ELISA, PK study | |
| A01858-40 | Anti-Ipilimumab Antibody (4H6)[Biotin], mAb, Mouse | - | ELISA, PK study |
Anti-Nivolumab/Opdivo (Target: PD-1)
| Cat. No. | Product Name | Inhibitory IC50 (μg/ml) | Recommend Applications | Recommended Pairs (Capture-Detection) |
|---|---|---|---|---|
| A01847-40 | Anti-Nivolumab Antibody(8G6G3D8), mAb, Mouse | Non-inhibitory | ELISA, PK study |
A01847-40 (C) - A01965-40 (D) A01847-40 (C) - A01848-40 (D) |
| A01965-40 | Anti-Nivolumab Antibody (6G5), mAb, Mouse | Non-inhibitory | ELISA, PK study | |
| A01848-40 | Anti-Nivolumab Antibody(6G5)[Biotin], mAb, Mouse | - | ELISA, PK study | |
| A01987-40 | MonoRab™ Anti-Nivolumab Antibody (33H4), mAb, Rabbit | 0.484 | ELISA, PK study |
A01987-40 (C) - A01988-40 (D) A01987-40 (C) - A01989-40 (D) |
| A01988-40 | MonoRab™ Anti-Nivolumab Antibody (40F11), mAb, Rabbit | 0.171 | ELISA, PK study | |
| A01989-40 | MonoRab™ Anti-Nivolumab Antibody (40F11)[Biotin], mAb, Rabbit | - | ELISA, PK study | |
| A01990-40 | MonoRab™ Anti-Nivolumab Antibody (47F6), mAb, Rabbit | 0.104 | DELISA, PK study | - |
| A01931-40 | Anti-Nivolumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay |
- |
Anti-Obinutuzumab/Gazyva (Target: CD20)
| Cat. No. | Product Name | Inhibitory IC50 (μg/ml) | Recommend Applications | Recommended Pairs (Capture-Detection) |
|---|---|---|---|---|
| A01945-40 | Anti-Obinutuzumab Antibody (18H8), mAb, Mouse | Non-inhibitory | ELISA, PK study |
A01945-40 (C) - A01946-40 (D) A01945-40 (C) - A01947-40 (D) |
| A01946-40 | Anti-Obinutuzumab Antibody (16B7), mAb, Mouse | Non-inhibitory | ELISA, PK study | |
| A01947-40 | Anti-Obinutuzumab Antibody (16B7) [Biotin], mAb, Mouse | - | ELISA, PK study | |
| A01966-40 | MonoRab™ Anti-Obinutuzumab Antibody (8G12), mAb, Rabbit | Non-inhibitory | ELISA, PK study |
A01966-40 (C) - A01967-40 (D) A01966-40 (C) - A01968-40 (D) |
| A01967-40 | MonoRab™ Anti-Obinutuzumab Antibody (169F10), mAb, Rabbit | Non-inhibitory | ELISA, PK study | |
| A01968-40 | MonoRab™ Anti-Obinutuzumab Antibody (169F10) [Biotin], mAb, Rabbit | - | ELISA, PK study | |
| A01933-40 | Anti-Obinutuzumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay |
- |
Anti-Omalizumab/Xolair (Target: Human IgE)
| Cat. No. | Product Name | Inhibitory IC50 (μg/ml) | Recommend Applications | Recommended Pairs (Capture-Detection) |
|---|---|---|---|---|
| A02095-40 | Anti-Omalizumab Antibody (10G3), mAb, Mouse | Non-inhibitory | ELISA, PK study | A02095-40 (C) - A02094-40 (D) |
| A02094-40 | Anti-Omalizumab Antibody (15B12), mAb, Mouse | Non-inhibitory | ELISA, PK study | |
| A02096-40 | Anti-Omalizumab Antibody (7G11), mAb, Mouse | 0.37 | ELISA, PK study | - |
| A02060-40 | Anti-Omalizumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
Anti-Palivizumab/Synagis (Target: RSV F)
| Cat. No. | Product Name | Inhibitory IC50 (μg/ml) | Recommend Applications | Recommended Pairs (Capture-Detection) |
|---|---|---|---|---|
| A02112-40 | Anti-Palivizumab Antibody (7B3), mAb, Mouse | 0.821 | ELISA, PK study | A02112-40 (C) - A02111-40 (D) |
| A02111-40 | Anti-Palivizumab Antibody (2F12), mAb, Mouse | Non-inhibitory | ELISA, PK study | |
| A02064-40 | Anti-Palivizumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
Anti-Panitumumab/Vectibix (Target: EGF Receptor)
| Cat. No. | Product Name | Inhibitory IC50 (μg/ml) | Recommend Applications | Recommended Pairs (Capture-Detection) |
|---|---|---|---|---|
| A02100-40 | Anti-Panitumumab Antibody (9G12), mAb, Mouse | Non-inhibitory | ELISA, PK study | A02100-40 (C) - A02099 (D) |
| A02099-40 | Anti-Panitumumab Antibody (2E7), mAb, Mouse | 0.567 | ELISA, PK study | |
| A02063-40 | Anti-Panitumumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
Anti-Pembrolizumab/Keytruda (Target: PD-1)
| Cat. No. | Product Name | Inhibitory IC50 (μg/ml) | Recommend Applications | Recommended Pairs (Capture-Detection) |
|---|---|---|---|---|
| A01844-40 | Anti-Pembrolizumab Antibody(1D6E10), mAb, Mouse | Non-inhibitory | ELISA, PK study | - |
| A01845-40 | Anti-Pembrolizumab Antibody(10E12C6)[Biotin], mAb, Mouse | 0.37 | ELISA, PK study | - |
| A02008-40 | MonoRab™ Anti-Pembrolizumab Antibody (94B9), mAb, Rabbit | 0.580 | ELISA, PK study | A02008-40 (C) - A02007-40 (D) |
| A02007-40 | MonoRab™ Anti-Pembrolizumab Antibody (47E5), mAb, Rabbit | 0.009 | ELISA, PK study | |
| A01960-40 | MonoRab™ Anti-Pembrolizumab Antibody (90G12), mAb, Rabbit | 0.38 | ELISA, PK study | - |
| A01853-40 | MonoRab™ Anti-Pembrolizumab Antibody(90G12)[Biotin], mAb, Rabbit | - | ELISA, PK study | - |
| A01846-40 | Anti-Pembrolizumab Antibody, pAb, Rabbit | - | ELISA,Immunogenicity assay | - |
Anti-Pertuzumab/Perjeta (Target: HER2)
| Cat. No. | Product Name | Inhibitory IC50 (μg/ml) | Recommend Applications | Recommended Pairs (Capture-Detection) |
|---|---|---|---|---|
| A02150-40 | Anti-Pertuzumab Antibody (1A3), mAb, Mouse | 0.387 | ELISA, PK study | A02150-40 (C) - A02151-40 (D) |
| A02151-40 | Anti-Pertuzumab Antibody (11H4), mAb, Mouse | 0.711 | ELISA, PK study |
Anti-Ranibizumab/Lucentis (Target: VEGF-A)
| Cat. No. | Product Name | Inhibitory IC50 (μg/ml) | Recommend Applications | Recommended Pairs (Capture-Detection) |
|---|---|---|---|---|
| A02035-40 | Anti-Ranibizumab Antibody (6C3), mAb, Mouse | 0.85 | ELISA, PK study | A02035-40 (C) - A02036-40 (D) |
| A02036-40 | Anti-Ranibizumab Antibody (10D12), mAb, Mouse | Non-inhibitory | ELISA, PK study | |
| A02037-40 | Anti-Ranibizumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay |
- |
Anti-Rituximab/Rituxan (Target: CD20)
| Cat. No. | Product Name | Inhibitory IC50 (μg/ml) | Recommend Applications | Recommended Pairs (Capture-Detection) |
|---|---|---|---|---|
| A01969-40 | Anti-Rituximab Antibody (6C1), mAb, Mouse | Non-inhibitory | ELISA, PK study |
A01969-40 (C) - A01970-40 (D) A01969-40 (C) - A01971-40 (D) |
| A01970-40 | Anti-Rituximab Antibody (17B6), mAb, Mouse | Non-inhibitory | ELISA, PK study | |
| A01971-40 | Anti-Rituximab Antibody (17B6)[Biotin], mAb, Mouse | - | ELISA, PK study | |
| A01942-40 | MonoRab™ Anti-Rituximab Antibody (137C6), mAb, Rabbit | Non-inhibitory | ELISA, PK study |
A01942-40 (C) - A01943-40 (D) A01942-40 (C) - A01944-40 (D) |
| A01943-40 | MonoRab™ Anti-Rituximab Antibody (194D7), mAb, Rabbit | Non-inhibitory | ELISA, PK study | |
| A01944-40 | MonoRab™ Anti-Rituximab Antibody (194D7)[Biotin], mAb, Rabbit | - | ELISA, PK study | |
| A01918-40 | Anti-Rituximab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay |
- |
Anti-Sarilumab/Kevzara (Target: IL-6 Receptor)
| Cat. No. | Product Name | Inhibitory IC50 (μg/ml) | Recommend Applications | Recommended Pairs (Capture-Detection) |
|---|---|---|---|---|
| A02042-40 | Anti-Sarilumab Antibody (26B10) , mAb, Mouse | 0.062 | ELISA, PK study | A02042-40 (C) - A02043-40 (D) |
| A02043-40 | Anti-Sarilumab Antibody (23H12) , mAb, Mouse | 0.056 | ELISA, PK study | |
| A02044-40 | Anti-Sarilumab Antibody (20F5), mAb, Mouse | Non-inhibitory | ELISA, PK study | - |
| A02122-40 | Anti-Sarilumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
Anti-Secukinumab/Cosentyx (Target: IL-17A)
| Cat. No. | Product Name | Inhibitory IC50 (μg/ml) | Recommend Applications | Recommended Pairs (Capture-Detection) |
|---|---|---|---|---|
| A02152-40 | Anti-Secukinumab Antibody (22G7), mAb, Mouse | 1.923 | ELISA, PK study | A02152-40 (C) - A02153-40 (D) |
| A02153-40 | Anti-Secukinumab Antibody (23E11), mAb, Mouse | 0.654 | ELISA, PK study |
Anti-Tocilizumab/Actemra (Target: IL-6 Receptor)
| Cat. No. | Product Name | Inhibitory IC50 (μg/ml) | Recommend Applications | Recommended Pairs (Capture-Detection) |
|---|---|---|---|---|
| A01978-40 | Anti-Tocilizumab Antibody (14B10), mAb, Mouse | Non-inhibitory | ELISA, PK study |
A01978-40 (C) - A01979-40 (D) A01978-40 (C) - A01980-40 (D) |
| A01979-40 | Anti-Tocilizumab Antibody (6C10), mAb, Mouse | 0.656 | ELISA, PK study | |
| A01980-40 | Anti-Tocilizumab Antibody (6C10)[Biotin], mAb, Mouse | - | ELISA, PK study | |
| A01932-40 | Anti-Tocilizumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
Anti-Trastuzumab/Herceptin (Target: HER2)
| Cat. No. | Product Name | Inhibitory IC50 (μg/ml) | Recommend Applications | Recommended Pairs (Capture-Detection) |
|---|---|---|---|---|
| A02032-40 | Anti-Trastuzumab Antibody (11C4), mAb, Mouse | - | ELISA, PK study | A02032-40 (C) - A02033-40 (D) |
| A02033-40 | Anti-Trastuzumab Antibody (15H2), mAb, Mouse | - | ELISA, PK study |
Anti-Ustekinumab/Stelara (Target: IL-12 & IL-23)
| Cat. No. | Product Name | Inhibitory IC50 (μg/ml) | Recommend Applications | Recommended Pairs (Capture-Detection) |
|---|---|---|---|---|
| A02118-40 | Anti-Ustekinumab Antibody (9A5), mAb, Mouse | Non-inhibitory | ELISA, PK study | A02118-40 (C) - A02117-40 (D) |
| A02117-40 | Anti-Ustekinumab Antibody (5F9), mAb, Mouse | Non-inhibitory | ELISA, PK study | |
| A02119-40 | Anti-Ustekinumab Antibody (11E3), mAb, Mouse | 0.5 | ELISA, PK study | - |
| A02123-40 | Anti-Ustekinumab Antibody, pAb, Rabbit | - | ELISA, Immunogenicity assay | - |
